These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33013747)

  • 21. Islet amyloid polypeptide/amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation.
    van Hulst KL; Oosterwijk C; Born W; Vroom TM; Nieuwenhuis MG; Blankenstein MA; Lips CJ; Fischer JA; Höppener JW
    Eur J Endocrinol; 1999 Jan; 140(1):69-78. PubMed ID: 10037255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residue specific effects of human islet polypeptide amyloid on self-assembly and on cell toxicity.
    Khemtemourian L; Guillemain G; Foufelle F; Killian JA
    Biochimie; 2017 Nov; 142():22-30. PubMed ID: 28778718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes?
    Johnson KH; O'Brien TD; Westermark P
    Diabetes; 1991 Mar; 40(3):310-4. PubMed ID: 1999270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide.
    Kapurniotu A; Bernhagen J; Greenfield N; Al-Abed Y; Teichberg S; Frank RW; Voelter W; Bucala R
    Eur J Biochem; 1998 Jan; 251(1-2):208-16. PubMed ID: 9492286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
    Caillon L; Lequin O; Khemtémourian L
    Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.
    Liang G; Zhao J; Yu X; Zheng J
    Biochemistry; 2013 Feb; 52(6):1089-100. PubMed ID: 23331123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor.
    Mirecka EA; Feuerstein S; Gremer L; Schröder GF; Stoldt M; Willbold D; Hoyer W
    Sci Rep; 2016 Sep; 6():33474. PubMed ID: 27641459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP).
    Krampert M; Bernhagen J; Schmucker J; Horn A; Schmauder A; Brunner H; Voelter W; Kapurniotu A
    Chem Biol; 2000 Nov; 7(11):855-71. PubMed ID: 11094339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
    Janson J; Soeller WC; Roche PC; Nelson RT; Torchia AJ; Kreutter DK; Butler PC
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7283-8. PubMed ID: 8692984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis.
    O'Brien TD; Butler PC; Kreutter DK; Kane LA; Eberhardt NL
    Am J Pathol; 1995 Sep; 147(3):609-16. PubMed ID: 7677175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered aggregation inhibitor fusion for production of highly amyloidogenic human islet amyloid polypeptide.
    Mirecka EA; Gremer L; Schiefer S; Oesterhelt F; Stoldt M; Willbold D; Hoyer W
    J Biotechnol; 2014 Dec; 191():221-7. PubMed ID: 24928165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.
    Anguiano M; Nowak RJ; Lansbury PT
    Biochemistry; 2002 Sep; 41(38):11338-43. PubMed ID: 12234175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc Chelator Inhibits Zinc-Induced Islet Amyloid Polypeptide Deposition and Apoptosis in INS-1 Cells.
    Tian H; Wang ZY
    Biol Trace Elem Res; 2019 May; 189(1):201-208. PubMed ID: 30027367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
    Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
    Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of islet amyloid polypeptide in fetal and adult porcine and human pancreatic islet cells.
    Lukinius A; Korsgren O; Grimelius L; Wilander E
    Endocrinology; 1996 Dec; 137(12):5319-25. PubMed ID: 8940352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
    Kapurniotu A
    Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease.
    Raimundo AF; Ferreira S; Martins IC; Menezes R
    Front Mol Neurosci; 2020; 13():35. PubMed ID: 32265649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.
    Wei L; Jiang P; Yau YH; Summer H; Shochat SG; Mu Y; Pervushin K
    Biochemistry; 2009 Mar; 48(11):2368-76. PubMed ID: 19146426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.